Physician profile
Terri Springer
NPI 1457631822
$4,331.31
in general payments reported to CMS, 2019-2025
15 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $402 · 2023: $1,239 · 2024: $2,348 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,156 · Travel and Lodging: $1,746 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,156.20 |
| Travel and Lodging | $1,745.89 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,546.84 | 2023-2025 | Interstim |
| Axonics, INC. | $891.52 | 2023 | Axonics |
| Boehringer Ingelheim Pharmaceuticals, INC. | $369.50 | 2022-2024 | Jardiance |
| Stryker Corporation | $306.55 | 2024-2025 | 1788 |
| Inspire Medical Systems, INC. | $252.32 | 2022-2023 | Inspire |
| Amgen INC. | $150.00 | 2025 | Krystexxa |
| Janssen Biotech, INC. | $149.21 | 2024 | Darzalex, Tecvayli |
| Pfizer INC. | $125.00 | 2023 | |
| Viiv Healthcare Company | $125.00 | 2022 | |
| Gilead Sciences, INC. | $121.87 | 2024 | Veklury |
| Shield Therapeutics INC | $107.76 | 2024 | |
| Biogen, INC. | $93.48 | 2023 | Spinraza |
| Guard Medical INC. | $47.29 | 2024 | Npseal Large |
| Davol INC. | $26.83 | 2025 | Phasix Mesh |
| Sanofi Pasteur INC. | $18.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terri Springer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.